Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lundbeck

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.

Creating a Movement for Social Prescribing

by Clark Health Communications for Lundbeck UK. ... Do Something Different: Helping Patients to Reach Functional Recovery in Depression – The FRAME Regional Meetings Programme - by Clark Health Communications for Lundbeck UK.

Digital disruption

Digital disruption R&D, this time within psychiatric and neurological treatments, was in the mind of Lundbeck executives when they signed a drug research deal with IBM Watson Health in February. ... Starting with projects in schizophrenia and Parkinson’s disease,

Novartis tie-up with IBM Watson Health in breast cancer

Novartis tie-up with IBM Watson Health in breast cancer Will combine real-world patient data and cognitive computing

FDA approves Teva's Huntington's disease drug at second attempt

FDA approves Teva's Huntington's disease drug at second attempt The green light gives patients with HD in the US the first alternative to Lundbeck's already approved Xenazine (tetrabenazine) drug, which was launched onto the market in 2008. ... sleepiness and nausea, only 5% of eligible patients are actually treated

Sam Agus takes up new role at Hansa Medical

Sam Agus takes up new role at Hansa Medical Agus has previously held various leading positions at several pharmaceutical companies includingAbbott Laboratories and most recently at H.Lundbeck A/S as it’s chief specialist, medical affairs neurology.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics